JP2021524856A5 - - Google Patents

Download PDF

Info

Publication number
JP2021524856A5
JP2021524856A5 JP2020565357A JP2020565357A JP2021524856A5 JP 2021524856 A5 JP2021524856 A5 JP 2021524856A5 JP 2020565357 A JP2020565357 A JP 2020565357A JP 2020565357 A JP2020565357 A JP 2020565357A JP 2021524856 A5 JP2021524856 A5 JP 2021524856A5
Authority
JP
Japan
Prior art keywords
membered
alkyl
heteroalkyl
cycloalkyl
hydroxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020565357A
Other languages
English (en)
Japanese (ja)
Other versions
JP7158500B2 (ja
JP2021524856A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/032925 external-priority patent/WO2019226490A1/en
Publication of JP2021524856A publication Critical patent/JP2021524856A/ja
Publication of JP2021524856A5 publication Critical patent/JP2021524856A5/ja
Priority to JP2022100465A priority Critical patent/JP7687996B6/ja
Application granted granted Critical
Publication of JP7158500B2 publication Critical patent/JP7158500B2/ja
Priority to JP2024113624A priority patent/JP2024153692A/ja
Priority to JP2026021958A priority patent/JP2026090413A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020565357A 2018-05-22 2019-05-17 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体 Active JP7158500B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2022100465A JP7687996B6 (ja) 2018-05-22 2022-06-22 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2024113624A JP2024153692A (ja) 2018-05-22 2024-07-16 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2026021958A JP2026090413A (ja) 2018-05-22 2026-02-13 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862674981P 2018-05-22 2018-05-22
US62/674,981 2018-05-22
PCT/US2019/032925 WO2019226490A1 (en) 2018-05-22 2019-05-17 Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022100465A Division JP7687996B6 (ja) 2018-05-22 2022-06-22 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体

Publications (3)

Publication Number Publication Date
JP2021524856A JP2021524856A (ja) 2021-09-16
JP2021524856A5 true JP2021524856A5 (cg-RX-API-DMAC10.html) 2021-12-09
JP7158500B2 JP7158500B2 (ja) 2022-10-21

Family

ID=66691073

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2020565357A Active JP7158500B2 (ja) 2018-05-22 2019-05-17 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2022100465A Active JP7687996B6 (ja) 2018-05-22 2022-06-22 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2024113624A Withdrawn JP2024153692A (ja) 2018-05-22 2024-07-16 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2026021958A Pending JP2026090413A (ja) 2018-05-22 2026-02-13 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2022100465A Active JP7687996B6 (ja) 2018-05-22 2022-06-22 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2024113624A Withdrawn JP2024153692A (ja) 2018-05-22 2024-07-16 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体
JP2026021958A Pending JP2026090413A (ja) 2018-05-22 2026-02-13 スルフィニルアミノベンズアミドおよびスルホニルアミノベンズアミド誘導体

Country Status (18)

Country Link
US (4) US11136290B2 (cg-RX-API-DMAC10.html)
EP (1) EP3796975B1 (cg-RX-API-DMAC10.html)
JP (4) JP7158500B2 (cg-RX-API-DMAC10.html)
KR (1) KR102667831B1 (cg-RX-API-DMAC10.html)
CN (3) CN118638096A (cg-RX-API-DMAC10.html)
AR (1) AR117576A1 (cg-RX-API-DMAC10.html)
AU (2) AU2019272538B2 (cg-RX-API-DMAC10.html)
DK (1) DK3796975T3 (cg-RX-API-DMAC10.html)
ES (1) ES2963524T3 (cg-RX-API-DMAC10.html)
FI (1) FI3796975T3 (cg-RX-API-DMAC10.html)
HU (1) HUE064831T2 (cg-RX-API-DMAC10.html)
LT (1) LT3796975T (cg-RX-API-DMAC10.html)
PL (1) PL3796975T3 (cg-RX-API-DMAC10.html)
PT (1) PT3796975T (cg-RX-API-DMAC10.html)
SI (1) SI3796975T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202300420T1 (cg-RX-API-DMAC10.html)
TW (2) TWI820437B (cg-RX-API-DMAC10.html)
WO (1) WO2019226490A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3796975T3 (da) 2018-05-22 2023-12-04 Orsobio Inc Sulfonylaminobenzamidderivater
TWI748194B (zh) 2018-06-28 2021-12-01 德商菲尼克斯 Fxr有限責任公司 含有雙環核心部分之新穎lxr調節劑
US20200397807A1 (en) 2019-06-18 2020-12-24 MitoPower, LLC Nicotinyl riboside compounds and their uses
US20230201144A1 (en) * 2020-05-29 2023-06-29 Novomedix, Llc Biarylsulfonamides and pharmaceutical compositions thereof, and their use for treating fibrotic lung disease
WO2025259921A1 (en) * 2024-06-13 2025-12-18 Orsobio, Inc. Compounds for modulating energy expenditure

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62257158A (ja) 1986-04-30 1987-11-09 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
US5290798A (en) 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
DE19642451A1 (de) 1996-10-15 1998-04-16 Merck Patent Gmbh Aminothiophencarbonsäureamide
WO2002018335A1 (en) * 2000-08-28 2002-03-07 Yamanouchi Pharmaceutical Co., Ltd. Cyclic amine derivatives
ATE476425T1 (de) 2003-05-29 2010-08-15 Merck Sharp & Dohme Triazolderivate als inhibitoren von 11-beta- hydroxysteroid-dehydrogenase-1
GB0323845D0 (en) 2003-10-10 2003-11-12 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
JP2005126374A (ja) 2003-10-24 2005-05-19 Kissei Pharmaceut Co Ltd 新規なアデノシンa2a受容体拮抗剤
BRPI0507626A (pt) 2004-02-11 2007-07-03 Irm Llc compostos e composiçoes como moduladores de lxr
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
CA2661293A1 (en) 2006-08-17 2008-02-21 Wellstat Therapeutics Corporation Combination treatment for metabolic disorders
TW200825054A (en) 2006-10-18 2008-06-16 Wyeth Corp Quinoline compounds
PT2142533E (pt) 2007-03-30 2012-01-19 Hoffmann La Roche Derivados de imidazolidinona
GB0708141D0 (en) 2007-04-26 2007-06-06 Syngenta Participations Ag Improvements in or relating to organic compounds
EP2210891A1 (en) 2009-01-26 2010-07-28 Domain Therapeutics New adenosine receptor ligands and uses thereof
MX355042B (es) 2009-06-08 2018-04-02 Acceleon Pharma Inc Metodos para aumentar adipositos termogenicos.
EA022375B1 (ru) 2011-04-22 2015-12-30 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРАЗОЛОСПИРОКЕТОНОВ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ АЦЕТИЛ-КоА-КАРБОКСИЛАЗ
KR20130142801A (ko) 2012-06-20 2013-12-30 안국약품 주식회사 11β-HSD1 효소의 억제활성을 갖는 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
WO2014065575A1 (ko) 2012-10-25 2014-05-01 주식회사유한양행 4,5-다이하이드로-1h-피라졸 유도체 또는 그의 염 및 이를 포함하는 약학 조성물
EP2990403A1 (en) 2014-08-29 2016-03-02 Novartis Tiergesundheit AG Anthranilamides, sulfonamides and nitro analogues derived therefrom as anthelmintics
HK1243636A1 (zh) 2014-11-18 2018-07-20 Rutgers, The State University Of New Jersey 用於治疗代谢疾病和癌症的新的线粒体解偶联剂
AR103232A1 (es) 2014-12-22 2017-04-26 Bristol Myers Squibb Co ANTAGONISTAS DE TGFbR
FR3037959B1 (fr) 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3458454B1 (en) * 2016-05-18 2021-11-24 Rutgers, The State University of New Jersey 2-hydroxy-n-(benzo[d]thiazol-2-yl)benzamide derivatives as mitochondrial uncouplers for the treatment of metabolic diseases and cancer
DK3796975T3 (da) 2018-05-22 2023-12-04 Orsobio Inc Sulfonylaminobenzamidderivater
TWI748194B (zh) 2018-06-28 2021-12-01 德商菲尼克斯 Fxr有限責任公司 含有雙環核心部分之新穎lxr調節劑
US20200397807A1 (en) * 2019-06-18 2020-12-24 MitoPower, LLC Nicotinyl riboside compounds and their uses
JPWO2023090411A1 (cg-RX-API-DMAC10.html) 2021-11-19 2023-05-25

Similar Documents

Publication Publication Date Title
JP7074674B2 (ja) Il-17の阻害及び他の使用のためのc4修飾オレアノール酸誘導体
AU2017219216B2 (en) Tetracyclic pyridone compounds as antivirals
JP2025528779A (ja) Pde4b阻害剤及びその用途
ES2441958T3 (es) Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4
JP6034883B2 (ja) ヘテロ三環状部分を有する抗ウイルス性化合物
CA3177252A1 (en) Heterocycle and glutarimide skeleton-based compounds and applications thereof
CN103827108B (zh) 丙型肝炎病毒抑制剂
MX2012006326A (es) Compuestos multiciclicos y metodos de uso de los mismos.
JP2019512505A5 (cg-RX-API-DMAC10.html)
TWI702223B (zh) 多烯巨環內酯衍生物
JP2018515521A (ja) ウイルス感染症の治療と予防のための新規置換アミノチアゾロピリミジンジオン
US20230312536A1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
TW202432557A (zh) 一種含氮雜環化合物、其藥學上可接受的鹽及其製備方法與應用
WO2011050284A1 (en) Pyrazolylpyridine antiviral agents
KR20150133767A (ko) 거대고리 염-유도성 키나아제 억제제
KR20170131644A (ko) 인단 아세트산 유도체를 사용한 간 질환의 치료 방법
CA3093553A1 (en) Compounds as modulators of tlr2 signaling
CA3169011A1 (en) Glutarimide skeleton-based compounds and uses thereof
JP2016517409A5 (cg-RX-API-DMAC10.html)
CN105399756A (zh) Btk抑制剂及其用途
CN114269747B (zh) 一种1’,2’-二氢-3’h-螺[环丁烷1,4’-异喹啉]-3’-酮衍生物及其应用
WO2019129114A1 (zh) 吲哚胺2,3-双加氧酶抑制剂以及它们在医学上的应用
CN116836176B (zh) 青蒿素类化合物、其制备方法和应用
CN119661620A (zh) 甾体化合物及其应用
TW202333697A (zh) Wnt通路抑制劑化合物